Cost-effectiveness analysis of simvastatin and lovastatin/extended- release niacin to achieve LDL and HDL goal using NHANES data.

Journal of managed care pharmacy : JMCP

Volumn 10, Issue 3, 2004, Pages 251-258

  Armstrong, Edward P ^a   Zachry 3rd , Woodie M ^a   Malone, Daniel C ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; SIMVASTATIN;

AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DRUG COMBINATION; FEMALE; HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME; UNITED STATES;

AGED; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MALE; MIDDLE AGED; NIACIN; SIMVASTATIN; TREATMENT OUTCOME; UNITED STATES;

EID: 4043152966     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2004.10.3.251     Document Type: Article

References (0)